These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29956121)

  • 1. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
    Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
    Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z
    Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk.
    Lehmann ML; Selinski S; Blaszkewicz M; Orlich M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Beg AE; Aslam M; Bánfi G; Romics I; Ickstadt K; Schwender H; Winterpacht A; Hengstler JG; Golka K
    Arch Toxicol; 2010 Dec; 84(12):967-78. PubMed ID: 21063684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk.
    Pattison JM; Posternak V; Cole MD
    Mol Cancer Res; 2016 Nov; 14(11):1078-1086. PubMed ID: 27514407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
    Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
    J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians.
    Singh V; Jaiswal PK; Mittal RD
    Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63.
    Martínez-Campelo L; Blanco-Verea A; López-Fernández T; Martínez-Monzonís A; Buño A; Mazón P; Zamora P; Norton N; Reddy JS; Velasco-Ruiz A; González-Neira A; Vulsteke C; Alonso-Gordoa T; Cruz R; Diz-de Almeida S; Carracedo A; González-Juanatey JR; López-Sendón J; Brion M;
    Sci Rep; 2024 Aug; 14(1):18413. PubMed ID: 39117733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
    Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
    Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Predisposition to the Mortality in Septic Shock Patients: From GWAS to the Identification of a Regulatory Variant Modulating the Activity of a
    Rosier F; Brisebarre A; Dupuis C; Baaklini S; Puthier D; Brun C; Pradel LC; Rihet P; Payen D
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine Mapping in Chromosome 3q28 Identified Two Variants Associated with Lung Cancer Risk in Asian Population.
    Wen Y; Zhu C; Li N; Li Z; Cheng Y; Dong J; Zhu M; Wang Y; Dai J; Ma H; Jin G; Dai M; Hu Z; Shen H
    J Cancer; 2019; 10(8):1862-1869. PubMed ID: 31205543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes.
    Wang Y; Wu W; Zhu M; Wang C; Shen W; Cheng Y; Geng L; Li Z; Zhang J; Dai J; Ma H; Chen L; Hu Z; Jin G; Shen H
    Int J Cancer; 2018 Apr; 142(8):1602-1610. PubMed ID: 29193083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common predisposition alleles for moderately common cancers: bladder cancer.
    Kiltie AE
    Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia.
    Hosgood HD; Wang WC; Hong YC; Wang JC; Chen K; Chang IS; Chen CJ; Lu D; Yin Z; Wu C; Zheng W; Qian B; Park JY; Kim YH; Chatterjee N; Chen Y; Chang GC; Hsiao CF; Yeager M; Tsai YH; Wei H; Kim YT; Wu W; Zhao Z; Chow WH; Zhu X; Lo YL; Sung SW; Chen KY; Yuenger J; Kim JH; Huang L; Chen YH; Gao YT; Kim JH; Huang MS; Jung TH; Caporaso N; Zhao X; Huan Z; Yu D; Kim CH; Su WC; Shu XO; Kim IS; Bassig B; Chen YM; Cha SI; Tan W; Chen H; Yang TY; Sung JS; Wang CL; Li X; Park KH; Yu CJ; Ryu JS; Xiang Y; Hutchinson A; Kim JS; Cai Q; Landi MT; Lee KM; Hung JY; Park JY; Tucker M; Lin CC; Ren Y; Perng RP; Chen CY; Jin L; Chen KC; Li YJ; Chiu YF; Tsai FY; Yang PC; Fraumeni JF; Seow A; Lin D; Zhou B; Chanock S; Hsiung CA; Rothman N; Lan Q
    Hum Genet; 2012 Jul; 131(7):1197-203. PubMed ID: 22367405
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
    G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
    Wu L; Chaffee KG; Parker AS; Sicotte H; Petersen GM
    Tumour Biol; 2015 Sep; 36(10):7431-7. PubMed ID: 25900876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional Variant (Rs35592567) in TP63 at 3q28 is Associated with Gastric Cancer Risk via Modifying its Regulation by MicroRNA-140.
    Lu C; Yang Y; Ma S
    Cell Physiol Biochem; 2018; 47(1):235-244. PubMed ID: 29763931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
    Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
    Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.
    Stern MC; Van Den Berg D; Yuan JM; Conti DV; Gago-Dominguez M; Pike MC; Xiang YB; Gao YT; Cortessis VK
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3057-61. PubMed ID: 19843673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.
    López Rodríguez M; Kaminska D; Lappalainen K; Pihlajamäki J; Kaikkonen MU; Laakso M
    Genome Med; 2017 Jul; 9(1):63. PubMed ID: 28683826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.